Concerning Link Between COVID Vaccination and Cancer Growth in the Wake of Pfizer’s $43 Billion Oncology Co. Acquisition

In a recent development that has sparked intrigue and concern, Pfizer completed a staggering $43 billion acquisition of Seagen on December 14, 2023, solidifying its position as the largest oncology company purportedly equipped to address cancers caused by mRNA vaccines. There’s an apparent link between COVID-19 vaccinations, specifically those utilizing mRNA technology, and an alarming surge in aggressive cancers, prompting serious safety concerns. The acquisition of Seagen is a move that positions the pharmaceutical giant as the largest player in the oncology market.

Pfizer’s acquisition of Seagen has raised eyebrows not only for its colossal price tag but also for the decision to issue $31 billion in debt to facilitate the purchase. Questions are circulating as to why Pfizer, a pharmaceutical giant with substantial resources, would opt for such a debt-heavy approach and overpay for a small cancer drug company that reports annual revenues of just $2 billion.

Pfizer’s COVID-19 mRNA vaccines, along with Moderna’s, are linked to the development of numerous forms of cancer. Researcher Dr. William Maki’s tweet states that cancers including lymphoma, brain cancer, breast cancer, colon cancer, and lung cancer are drastically increasing. Specifically, the CEO of Pfizer claims 33% of people are bound to develop cancer:

– 33% of people WILL get cancer (he’s certain)
– entire families WILL be affected (he’s certain)
– The new cancer treatments are like “missiles” that will target “most” cancers
– he will produce them AT A SCALE THAT HAS NOT BEEN SEEN BEFORE.
– 2025
– “We have a Global Network”
– “We have very quick way of completing clinical trials”
– will be produced “AT SCALE”, “just like mRNA”

NEW ARTICLE: Pfizer completes $43 Billion acquisition of Seagen on Dec.14, 2023 – becomes largest oncology company to treat most TURBO CANCERS caused by mRNA Vaccines – deep dive into the sinister aspects of this very bizarre deal.

Pfizer OVERPAYS $43 billion on small Cancer… pic.twitter.com/ygoHDbVZcE

— William Makis MD (@MakisMD) December 17, 2023

The dramatic rise in cancer, especially among young adults, raises serious concerns about potential side effects from the COVID-19 vaccination. But equally troubling, why would one of the world’s largest manufacturers of the COVID vaccine pay a premium for the largest oncology company in the world? What does Pfizer know about the COVID vaccine’s link to surging cancer rates and when did it know it?
Delete Facebook, Delete Twitter, Follow Restoring Liberty and Joe Miller at gab HERE.